| scholarly article | Q13442814 |
| P2093 | author name string | Marcelo M Pinheiro | |
| Vera L Szejnfeld | |||
| Paulo G Pedreira | |||
| P2860 | cites work | Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis | Q83127754 |
| Bone mineral density and bone turnover in patients with psoriatic arthritis. | Q51736987 | ||
| Angiopoietins, growth factors, and vascular morphology in early arthritis. | Q52860641 | ||
| Studies on psoriatic osteopathy. | Q54300166 | ||
| Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study | Q59538331 | ||
| Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFα, and IL-7 in anin vitromodel derived from human psoriatic arthritis | Q61043823 | ||
| Decreased bone mineral density in patients with pustulosis palmaris et plantaris | Q71669450 | ||
| Body composition in rheumatoid arthritis | Q73356123 | ||
| Bone mineral density in patients with psoriatic arthritis | Q73483663 | ||
| Bone mineral density of patients with chronic plaque psoriasis | Q74318683 | ||
| A comparison of bone mineral density in Indians with psoriatic polyarthritis and healthy Indian volunteers | Q75356990 | ||
| Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis | Q79190342 | ||
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
| Bone loss in patients with psoriatic arthritis and psoriasis vulgaris | Q80237783 | ||
| Outcome measures in psoriatic arthritis | Q80261276 | ||
| Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis | Q80825707 | ||
| Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis | Q81050476 | ||
| UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis | Q81095548 | ||
| Tumour necrosis factor-related apoptosis-inducing ligand and osteoprotegerin serum levels in psoriatic arthritis | Q83017998 | ||
| Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report | Q34307115 | ||
| Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
| Severe Psoriasis – Oral Therapy with a New Retinoid | Q34690752 | ||
| Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis | Q34967810 | ||
| Musculoskeletal aging | Q35652822 | ||
| Effects of aging on muscle fibre type and size | Q35907563 | ||
| Immunopathology of psoriasis and psoriatic arthritis | Q36040037 | ||
| Cachexia: pathophysiology and clinical relevance | Q36442937 | ||
| Epidemiology of osteoporosis in rheumatic diseases. | Q36731577 | ||
| Psoriasis: the epidermal component | Q37005297 | ||
| Psoriasis and metabolic disease: epidemiology and pathophysiology | Q37102789 | ||
| Nutrient intakes related to osteoporotic fractures in men and women--the Brazilian Osteoporosis Study (BRAZOS). | Q37107207 | ||
| Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies | Q37163337 | ||
| From skin to bone: translational perspectives on psoriatic disease | Q37210197 | ||
| Immunopathogenesis of psoriasis | Q40175802 | ||
| Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women | Q40532490 | ||
| Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. | Q44076079 | ||
| Vertebral fracture assessment using a semiquantitative technique. | Q45969757 | ||
| Clinical risk factors for osteoporotic fractures in Brazilian women and men: the Brazilian Osteoporosis Study (BRAZOS). | Q46505457 | ||
| Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment | Q47239427 | ||
| Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. | Q47261263 | ||
| Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. | Q47340019 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | R16 | |
| P577 | publication date | 2011-02-07 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis | |
| P478 | volume | 13 |
| Q47204631 | Addressing comorbidities in psoriatic disease |
| Q50932005 | Bone Mineral Density, 25-OH Vitamin D and Inflammation in Patients with Psoriasis. |
| Q41687204 | Bone mineral density in patients with psoriatic arthritis: data from the Nord-Trøndelag Health Study 3. |
| Q35060640 | Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. |
| Q37198846 | Carotid plaque and bone density and microarchitecture in psoriatic arthritis: the correlation with soluble ST2 |
| Q92733573 | Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis? |
| Q59123603 | Density, structure, and strength of the distal radius in patients with psoriatic arthritis: the role of inflammation and cardiovascular risk factors |
| Q47831537 | Differences in bone structure between rheumatoid arthritis and psoriatic arthritis patients relative to autoantibody positivity. |
| Q38402703 | EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. |
| Q33991868 | Effect of body composition on bone mineral density in Moroccan patients with juvenile idiopathic arthritis |
| Q26741784 | Environmental Risk Factors in Psoriasis: The Point of View of the Nutritionist |
| Q89579551 | Higher bodily adiposity, fat intake, and cholesterol serum levels are associated with higher disease activity in psoriatic arthritis patients: is there a link among fat and skin and joint involvement? |
| Q35866345 | Low fatness, reduced fat intake and adequate plasmatic concentrations of LDL-cholesterol are associated with high bone mineral density in women: a cross-sectional study with control group |
| Q35047630 | Nutrition and psoriasis: is there any association between the severity of the disease and adherence to the Mediterranean diet? |
| Q26778275 | Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response |
| Q90299559 | Osteoporosis in psoriatic arthritis: a cross-sectional study of an outpatient clinic population |
| Q48023363 | Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures |
| Q82732857 | Osteoporosis in psoriatic arthritis: is there any? |
| Q44251450 | Prevalence and risk factors associated with low-impact fractures in men with rheumatoid arthritis |
| Q39309938 | Psoriasis, fracture risk and bone mineral density: the HUNT Study, Norway |
| Q28088340 | Psoriasis: classical and emerging comorbidities |
| Q28073922 | Psoriasis: new comorbidities |
| Q41134931 | Quantitative and Qualitative Changes of Bone in Psoriasis and Psoriatic Arthritis Patients |
| Q27025534 | Relationships between Adipose Tissue and Psoriasis, with or without Arthritis |
| Q36175115 | The Epidemiology of Psoriatic Arthritis |
| Q90397063 | The Interrelations between Biological and Targeted Synthetic Agents Used in Inflammatory Joint Diseases, and Obesity or Body Composition |
| Q36202422 | The prevalence of vertebral fractures in spondyloarthritis: relation to disease characteristics, bone mineral density, syndesmophytes and history of back pain and trauma |
| Q38694904 | The relevance of serum vitamin D in psoriasis: a review |
| Q86765414 | Vitamin D status in men with psoriatic arthritis: a case-control study |
| Q40955608 | Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. |
Search more.